NAT14 Antibody

• Catalog Number: orb1880988
• Category: Antibodies
• Description: The NAT14 Antibody is suitable for IHC, WB. It is a Polyclonal, Unconjugated antibody which raised against KLH-conjugated synthetic peptide encompassing a sequence within the N-terminal region of human NAT14. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography.
• Clonality: Polyclonal
• Species/Host: Rabbit
• Conjugation: Unconjugated
• Reactivity: Human
• Form/Appearance: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
• Purification: The antibody was purified by immunogen affinity chromatography.
• Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the N-terminal region of human NAT14. The exact sequence is proprietary.
• UniProt ID: Q8WUY8
• Tested applications: IHC, WB
• Dilution range: WB (1/500 - 1/1000), IH (1/50 - 1/200)
• Antibody Type: Primary Antibody
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Alternative names: KLP1; N-acetyltransferase 14; K562 cell-derived le
• Note: For research use only
• Entrez: 57106

Western blot analysis of NAT14 expression in K562 (A) whole cell lysates. (Predicted band size: 21 kD; Observed band size: 16 kD)

Immunohistochemical analysis of NAT14 staining in human hepatocarcinoma formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.